Articles

1. Non-serious case reports

   News item 18 May 2024 Pages: 362 - 363

2. Zoledronicn acid

   Case report 18 May 2024 Pages: 361 - 361

3. Yttrium-90

   Case report 18 May 2024 Pages: 360 - 360

4. Xylazine

   Case report 18 May 2024 Pages: 359 - 359

5. Warfarin

   Case report 18 May 2024 Pages: 358 - 358

6. Vortioxetine

   Case report 18 May 2024 Pages: 357 - 357

7. Voriconazole

   Case report 18 May 2024 Pages: 356 - 356

8. Vismodegib

   Case report 18 May 2024 Pages: 355 - 355

9. Venetoclax

   Case report 18 May 2024 Pages: 354 - 354

10. Vedolizumab

    Case report 18 May 2024 Pages: 353 - 353

11. Vancomycin

    Case report 18 May 2024 Pages: 352 - 352

12. Vancomycin

    Case report 18 May 2024 Pages: 351 - 351

13. Valproic-acid

    Case report 18 May 2024 Pages: 350 - 350

14. Upadacitinib

    Case report 18 May 2024 Pages: 349 - 349

15. Upadacitinib

    Case report 18 May 2024 Pages: 348 - 348

16. Trastuzumab/trastuzumab-emtansine

    Case report 18 May 2024 Pages: 347 - 347

17. Tozinameran

    Case report 18 May 2024 Pages: 346 - 346

18. Tozinameran

    Case report 18 May 2024 Pages: 345 - 345

19. Tozinameran

    Case report 18 May 2024 Pages: 344 - 344

20. Tozinameran

    Case report 18 May 2024 Pages: 343 - 343

21. Tozinameran

    Case report 18 May 2024 Pages: 342 - 342

22. Tozinameran

    Case report 18 May 2024 Pages: 341 - 341

23. Tofacitinib

    Case report 18 May 2024 Pages: 340 - 340

24. Tisotumab-vedotin

    Case report 18 May 2024 Pages: 339 - 339

25. Tislelizumab

    Case report 18 May 2024 Pages: 338 - 338

26. Tirzepatide

    Case report 18 May 2024 Pages: 337 - 337

27. Tirzepatide

    Case report 18 May 2024 Pages: 336 - 336

28. Tirabrutinib

    Case report 18 May 2024 Pages: 335 - 335

29. Timolol

    Case report 18 May 2024 Pages: 334 - 334

30. Thyrotropin-alfa

    Case report 18 May 2024 Pages: 333 - 333

31. Thiamazole

    Case report 18 May 2024 Pages: 332 - 332

32. Thalidomide

    Case report 18 May 2024 Pages: 331 - 331

33. Terbutaline/Theophylline

    Case report 18 May 2024 Pages: 330 - 330

34. Teprotumumab

    Case report 18 May 2024 Pages: 329 - 329

35. Telmisartan

    Case report 18 May 2024 Pages: 328 - 328

36. Teclistamab

    Case report 18 May 2024 Pages: 327 - 327

37. Tacrolimus/Warfarin

    Case report 18 May 2024 Pages: 326 - 326

38. Tacrolimus

    Case report 18 May 2024 Pages: 325 - 325

39. Tacrolimus

    Case report 18 May 2024 Pages: 324 - 324

40. Tacrolimus

    Case report 18 May 2024 Pages: 323 - 323

41. Sodium-polystyrene-sulfonate

    Case report 18 May 2024 Pages: 322 - 322

42. Sodium-chloride

    Case report 18 May 2024 Pages: 321 - 321

43. Sodium amidotrizoate/diatrizoate meglumine

    Case report 18 May 2024 Pages: 320 - 320

44. Sintilimab

    Case report 18 May 2024 Pages: 319 - 319

45. Simvastatin

    Case report 18 May 2024 Pages: 318 - 318

46. Secukinumab

    Case report 18 May 2024 Pages: 317 - 317

47. Safinamide

    Case report 18 May 2024 Pages: 316 - 316

48. Ruxolitinib

    Case report 18 May 2024 Pages: 315 - 315

49. Rivaroxaban

    Case report 18 May 2024 Pages: 314 - 314

50. Rituximab/tofacitinib

    Case report 18 May 2024 Pages: 313 - 313